ALLIE HAUGHEY: Open Payments
NPI 1376070391 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 7 payments from 5 companies in 2025. Trend: 2023 $19 · 2024 $22 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Alkermes, Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $14 |
Products named: CAPLYTA, TRINTELLIX, ARISTADA, INGREZZA, VRAYLAR.
Industry payments across AR — which companies pay providers there.
